
Negative Sodium Balance in Lithium Carbonate ToxicityEvidence of Mineralocorticoid Blockade
Leslie Baer, MD;
Alexander H. Glassman, MD;
Suham Kassir
Arch Gen Psychiatry. 1973;29(6):823-827.
Abstract
The patients reported developed lithium carbonate toxicity while being maintained on a constant sodium and fluid intake. Negative sodium balance was observed in both patients coincident with the onset of lithium carbonate toxicity. Negative sodium balance was also observed in lithium carbonate-toxic rats.
The renal response to the mineralocorticoid deoxycorticosterone acetate (DOC) was evaluated in groups of control and lithium carbonate-treated rats in order to further explore the renal mechanisms involved in lithium carbonate toxicity. In established lithium carbonate toxicity, a blunted response to the sodium retaining properties of DOC was present.
Accordingly, these observations demonstrate a pathogenic cycle in lithium carbonate toxicity. Mineralocorticoid blockade induced by already toxic concentrations of lithium carbonate promotes renal sodium wasting which in turn leads to further lithium carbonate retention and increased toxicity.
Author Affiliations
New York
From the departments of medicine and psychiatry, Columbia University College of Physicians & Surgeons and the New York State Psychiatric Institute, New York.
Footnotes
Accepted for publication July 24, 1973.
Reprint requests to 722 W 168th St, New York, NY 10032 (Dr. Baer).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Lithium-induced NDI in rats is associated with loss of {alpha}-ENaC regulation by aldosterone in CCD
Nielsen et al.
Am. J. Physiol. Renal Physiol. 2006;290:F1222-F1233.
ABSTRACT
| FULL TEXT
Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI
Nielsen et al.
Am. J. Physiol. Renal Physiol. 2003;285:F1198-F1209.
ABSTRACT
| FULL TEXT
Chronic Lithium Treatment Inhibits Amiloride-Sensitive Sodium Transport in the Rat Distal Nephron
Thomsen et al.
J. Pharmacol. Exp. Ther. 1999;289:443-447.
ABSTRACT
| FULL TEXT
|